Here are four highlights:
1. The market will see a 10.2 percent compound annual growth rate from 2017 to 2021.
2. Advancements in minimally invasive surgery, reduction in healthcare costs and an increase in the geriatric population will drive the market during the forecast period.
3. In 2015, North America accounted for the largest share of the minimally invasive surgical devices market. However, the Asia-Pacific market is expected to see the most growth throughout the forecast period.
4. Key market competitors include Medtronic, Stryker, Smith & Nephew and Aesculap.
More articles on MIS:
Misonix reports $7.3M in Q1 2018 revenue — 5 takeaways
Renew Spine Care and SpineMark team up to make MIS spine mainstream
MIS vs. nonsurgical management of sacroiliac joint pain: 4 key findings
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.